Thu 6/21/2018 04:26 ET
DJIA24657.8042.410.17%TELCO155.901.561.00%GOLD1266.108.360.66%Shanghai2875.8139.401.37%
S&P 5002767.324.700.17%BANKS467.950.610.13%OIL65.060.651.00%BITCOIN6741.2520.220.30%
NASDAQ7781.5256.030.72%PHARM507.691.170.23%US/EU1.170.000.26%Futures2775.253.250.12%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (EARTH SCIENCE TECH - ETST)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ETST
  
From: NetworkNewsWire (Rep: 0)Date: 03/13/2018 20:56
Forum: Wall Street Pit - Msg #2724512 - List ETST msgs Thread #673997265 (Rec: 0)
Earth Science Tech, Inc. (ETST): Transparency, Scientific Research and Future Products

- Received grant from Government of Québec through Canno Inno Laboratories subsidiary
- Canna Inno Laboratories enhances collaboration between the company’s resources in Canada and the U.S. while providing access to grants
- Sound scientific research and transparent studies

Earth Science Tech, Inc. (OTC: ETST), a Florida-based biotechnology company focused on cannabis, industrial hemp and cannabinoid research and development for nutraceuticals, pharmaceuticals and medical devices, announced last week that its subsidiary, Canna Inno Laboratories Inc., has received a grant from the Government of Québec for innovation in the pharmaceutical industry. ETST plans to apply for additional funding under Canada’s Scientific Research and Experimental Development Tax Credit program (http://nnw.fm/YN2cr).

Earth Science Tech formed Canna Inno Laboratories, Inc. in 2017. Strategically headquartered in Montreal, Quebec, it allows Earth Science Tech access to Canadian government and private grants offered to companies for innovation in the pharmaceutical industry. The awarded grant will support the pre-launch process of Earth Science’s three CBD-based products. These nutraceutical products aim to prevent common causes of cancer and help reduce occurrence rates. The pre-launch process includes a series of pre-clinical in vitro trials to fight breast cancer and neurodegenerative disorders. Once complete and patent pending, these high-grade hemp CBD oil products will be commercialized as nutraceuticals and provide alternative natural treatment solutions.

Through the in vitro study with the University of Central Oklahoma and DV Biologics, ETST has provided results that confirm the positive effect of its CBD on breast cancer, immune cell function and human brain cells. The goal of ETST is to discover solutions for conditions that currently have no effective treatment, targeting diseases in which the benefits of CBD have already been demonstrated by researchers worldwide. ETST seeks to increase the effectiveness of cannabinoids and/or CBD and thereby improve treatments for different diseases. The company focuses on providing sound scientific research and transparency on the progression of studies done on its highest quality and purity, full spectrum high-grade hemp CBD products.

For more information, visit the company’s website at www.EarthScienceTech.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser NetworkNewsWire: Reward | Watch | IgnoreETST: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add ETST
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.